Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today reported that the company has shipped over $5 million of its explosives trace detectors (ETDs) across five continents over the past two months. These sales, which include a combination of QS-B220 desktop explosives and drugs trace detectors and QS-H150 handheld explosives trace detectors, do not include its TSA shipments, which have also begun to ship to airports across the United States.
"Implant Sciences' growth has been impressive over the past year, but more importantly, we're seeing that it is sustainable, long-term growth. Our company is recognized as a true market leader in the trace detection industry, and we continue to win contracts despite significant competition in the market," stated Dr. Darryl Jones, Implant Sciences' Executive Vice President.
"Customers evaluating ETDs are seeing the impressive value proposition of our QS-B220 and QS-H150. As a company, it's our mission to provide our customers with the best detection performance in the industry while offering a solution that will not be cost-prohibitive to own and maintain," added Robert Liscouski, Implant Sciences' President. "Customers continue to choose our systems across multiple applications, which demonstrates that our mission is being accomplished. We are very pleased to continue our market share gain."
Source: Implant Sciences Corporation
Date: Jan 15, 2016